BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 4005139)

  • 21. Improved screening for colorectal cancer by immunological detection of occult blood.
    Frommer DJ; Kapparis A; Brown MK
    Br Med J (Clin Res Ed); 1988 Apr; 296(6629):1092-4. PubMed ID: 3132220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experience with haemoccult screening in Hungary. A multicenter trial.
    Siba S
    Hepatogastroenterology; 1983 Feb; 30(1):27-9. PubMed ID: 6601046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemical and immunological testing for faecel occult blood: a comparison of two tests in symptomatic patients.
    Thomas WM; Hardcastle JD; Jackson J; Pye G
    Br J Cancer; 1992 Apr; 65(4):618-20. PubMed ID: 1562472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of dietary restriction in Haemoccult screening for colorectal cancer.
    Thomas WM; Pye G; Hardcastle JD; Chamberlain J; Charnley RM
    Br J Surg; 1989 Sep; 76(9):976-8. PubMed ID: 2679967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Haemoscreen in comparison with haemoccult as screening test for colorectal carcinoma (author's transl)].
    Gnauck R; Thomas L
    Dtsch Med Wochenschr; 1980 Nov; 105(47):1643-6. PubMed ID: 7439045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening for colorectal cancer in a Hungarian county.
    Ujszászy L; Prónay G; Nagy G; Kovács J; Libor J; Minik K
    Endoscopy; 1985 May; 17(3):109-12. PubMed ID: 4006870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accuracy of occult blood tests over a six-day period.
    Farrands PA; Hardcastle JD
    Clin Oncol; 1983 Sep; 9(3):217-25. PubMed ID: 6616996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Sensitivity of the haemoccult test in colorectal tumours (author's transl)].
    Schewe S; Feifel G; Heldwein W; Weinzierl M; Wolf W; Bolte HD; Konrad E
    Dtsch Med Wochenschr; 1979 Feb; 104(7):253-6. PubMed ID: 761519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Faecal occult blood testing and colonoscopy in the surveillance of subjects at high risk of colorectal neoplasia.
    Robinson MH; Kronborg O; Williams CB; Bostock K; Rooney PS; Hunt LM; Hardcastle JD
    Br J Surg; 1995 Mar; 82(3):318-20. PubMed ID: 7795994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Screening for colorectal cancer with the Haemoccult test (author's transl)].
    Gnauck R
    Leber Magen Darm; 1977 Feb; 7(1):32-5. PubMed ID: 839951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Self-reported dark red bleeding as a marker comparable with occult blood testing in screening for large bowel neoplasms.
    Silman AJ; Mitchell P; Nicholls RJ; Macrae FA; Leicester RJ; Bartram CI; Simmons MJ; Campbell PD; Hearn CE; Constable PJ
    Br J Surg; 1983 Dec; 70(12):721-4. PubMed ID: 6605779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical experience with occult blood test in 8784 patients (author's transl)].
    Weiss W; Samec HJ; Gulz W; Ortner H; Rüdiger E; Neumayr A
    Wien Klin Wochenschr; 1981 May; 93(9):291-6. PubMed ID: 6973245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mass screening for colorectal cancer in Hungary.
    Preisich P; Siba S; Szakátsy E
    J R Soc Med; 1987 Jun; 80(6):352-3. PubMed ID: 3625689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening for colorectal neoplasms with a new immunological human faecal haemoglobin and albumin test.
    Sieg A; Hertel A; John MR; Lüthgens K; Schmidt-Gayk H
    Eur J Cancer Prev; 1998 Aug; 7(4):279-85. PubMed ID: 9806116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Occult blood screening for colorectal cancer].
    Kumanishi Y; Fujita M; Taguchi T
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2255-62. PubMed ID: 3729485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. False-negative results of Haemoccult test in colorectal cancer.
    Anderson JM
    Br Med J (Clin Res Ed); 1981 Oct; 283(6299):1123-4. PubMed ID: 6794788
    [No Abstract]   [Full Text] [Related]  

  • 37. Occult faecal blood loss determined by a 51Cr method and chemical tests in patients referred for colonoscopy.
    Dybdahl JH; Daae LN; Larsen S; Myren J
    Scand J Gastroenterol; 1984 Mar; 19(2):245-54. PubMed ID: 6609422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenoma residua in colorectal cancer. A study of 34 colorectal cancers detected by an immunological occult blood test.
    Häkkinen I; Järvi O; Nylamo E; Söderström KO
    Ann Chir Gynaecol; 1993; 82(1):31-5. PubMed ID: 8323234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunological detection of occult blood in bowel cancer patients.
    Kapparis A; Frommer D
    Br J Cancer; 1985 Dec; 52(6):857-61. PubMed ID: 3935151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Feasibility of fecal occult-blood testing for detection of colorectal neoplasia: debits and credits.
    Winawer SJ; Miller DG; Schottenfeld D; Leidner SD; Sherlock P; Befler B; Stearns MW
    Cancer; 1977 Nov; 40(5 Suppl):2616-9. PubMed ID: 922702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.